← Back to Clinical Trials
Recruiting NCT07124780

NCT07124780 Helping Adults With Obsessive-Compulsive Disorder Succeed at Work

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07124780
Status Recruiting
Phase —
Sponsor New York State Psychiatric Institute
Condition Obsessive-Compulsive Disorder (OCD)
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-05-12
Primary Completion 2027-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Individual Placement and Support (IPS)Standard Vocational Services

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-05-12 with a primary completion date of 2027-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to compare two models of employment services for people with obsessive-compulsive disorder (OCD) interested in finding and maintaining employment. All 40 participants will receive up to 12 sessions of the first-line treatment for OCD called exposure and response prevention, a form of Cognitive Behavioral Therapy (CBT). Assigned by chance, half of the people will also receive Individual Placement and Support (IPS); the other half will receive standard vocational services (SVS). This study will compare these two approaches for helping adults with OCD find and maintain work.

Eligibility Criteria

Inclusion Criteria: * Currently unemployed and interested in finding competitive employment in New York State * Currently residing in New York State * Primary diagnosis of OCD * For those currently on psychiatric medication: On a stable dose of psychiatric medication (for at least 6 weeks) and willing to remain on this dose for the first three months of CBT. * Access to the internet through a mobile device or computer Exclusion Criteria: * In the process of applying for or currently receiving disability benefits * Currently receiving supported employment services * Active suicidality or recent suicide attempt * Active substance use problem (other than nicotine) that warrants treatment * Comorbid psychiatric conditions that significantly elevate the risk of study participation such as psychotic disorders or bipolar disorder

Contact & Investigator

Central Contact

Sapana R. Patel, Ph.D.

✉ sapana.patel@nyspi.columbia.edu

📞 646-774-8491

Principal Investigator

Sapana R Patel, Ph.D.

PRINCIPAL INVESTIGATOR

The New York State Psychiatric Institute

Frequently Asked Questions

Who can join the NCT07124780 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Obsessive-Compulsive Disorder (OCD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07124780 currently recruiting?

Yes, NCT07124780 is actively recruiting participants. Contact the research team at sapana.patel@nyspi.columbia.edu for enrollment information.

Where is the NCT07124780 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT07124780 clinical trial?

NCT07124780 is sponsored by New York State Psychiatric Institute. The principal investigator is Sapana R Patel, Ph.D. at The New York State Psychiatric Institute. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology